Package Leaflet: Information for the Patient
Feraccru 30 mg Hard Capsules
Iron (as ferric maltol)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Feraccru contains iron (as ferric maltol). Feraccru is used in adults to treat low iron levels in the body. Low iron levels cause anaemia (very few red blood cells).
Do not take Feraccru:
Warnings and precautions
Before starting treatment, your doctor will do a blood test to make sure your anaemia is not severe and is not caused by anything other than low iron levels.
Do not take Feraccru if you are experiencing an "exacerbation or flare-up" of your IBD.
Children and adolescents
Do not give Feraccru to children or adolescents under 18 years, as the use of this medicine has not been studied in this age group. Excess iron is dangerous in young children and can be potentially fatal.
Using Feraccru with other medicines
Tell your doctor or pharmacist if you are taking any of these medicines.
You should leave a gap of two hours between taking Feraccru and taking:
Do not receive iron by injection or infusion (intravenously) while taking Feraccru.
Do not take Feraccru if you are taking dimercaprol (a medicine used to remove toxic metals from the blood), chloramphenicol (used to treat bacterial infections) or methyldopa (used to treat high blood pressure).
Pregnancy and breast-feeding
Preferably, do not take Feraccru if you are pregnant or breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Feraccru is not expected to affect your ability to drive and use machines.
The Feraccru capsules contain lactose, Sunset Yellow FCF (E110) and Allura Red AC (E129)
Lactose: If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Sunset Yellow (E110) and Allura Red (E129): May cause allergic reactions.
Follow exactly the administration instructions of this medicine given by your doctor.
Adults (18 years and over)
Take Feraccru on an empty stomach, with half a glass of water (one hour before a meal or at least 2 hours after a meal). The recommended dose is one capsule (30 mg) taken twice a day, in the morning and in the afternoon.
Swallow the capsules whole.
If you take more Feraccru than you should
Taking too much Feraccru may make you feel sick or vomit and may cause stomach pain and diarrhoea. Call your doctor or hospital immediately if you or someone else has taken too much Feraccru. Make sure to take this leaflet and any remaining capsules with you to show to your doctor.
If you forget to take Feraccru
Miss the dose that you forgot and take the next dose as normal. Do not take a double dose to make up for a forgotten capsule.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effects of Feraccru (may affect up to 1 in 10 people) are:
Uncommon side effects (may affect up to 1 in 100 people) are: thirst, joint stiffness, pain in the fingers/toes, headache, erythema, vomiting and increased intestinal bacteria. Blood tests may show higher levels of enzymes that break down chemicals in the blood and of a hormone that stimulates the thyroid gland.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after ‘EXP’. The expiry date refers to the last day of that month.
Do not use this medicine more than 45 days after first opening the bottle.
Do not store the capsules above 25°C.
What is in Feraccru
The active substance is 30 mg of iron as ferric maltol.
The other ingredients are:
Appearance of Feraccru and pack contents
Feraccru is a hard capsule of red colour containing a reddish-brown powder.
Feraccru is available in bottles, each containing 56 capsules.
Marketing Authorisation Holder
Norgine B.V.
Antonio Vivaldistraat 150
1083 HP Amsterdam
Netherlands
Manufacturer
Piramal Healthcare UK Limited
Whalton Road
Morpeth
Northumberland
NE61 3YA, UNITED KINGDOM
Patheon France
40 boulevard de champaret
38300 Bourgoin-Jallieu
FRANCE
You can request more information about this medicine from the local representative of the Marketing Authorisation Holder:
BE\ LU Norgine NV/SA +32 16 39 27 10 medinfo.benelux@norgine.com | AT\BG\CZ\DK\FI\HR\HU\IS\NO\PL\ RO\SE\SI\SK AOP Orphan Pharmaceuticals AG +43-1-503-72-44 office@aoporphan.com |
DE Norgine GmbH +49 641984970 info@norgine.de | IE/UK Norgine Pharmaceuticals Ltd. +44 1895 826666 MedInfo@norgine.com |
ES Norgine de España, S.L.U +34 91 375 8870 iberiamedinfo@norgine.com | FR Norgine SAS +33 141399400 infomedicale.norginefrance@norgine.com |
IT Norgine Italia S.r.l. +39 0267 977211 medinfoitaly@norgine.com | NL Norgine B.V. +31 20 567 0900 medinfo.benelux@norgine.com |
PT Norgine Portugal Farmacêutica Unipessoal, Lda +351 218952735 iberiamedinfo@norgine.com | EE\EL\CY\LV\LT\MT Norgine B.V. +44 1895 826600 GMedicalAffairs@norgine.com |
Date of last revision of this leaflet xxx
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.